Leukemia, Lymphoid: all 1,772 studies
Page 1 of 18. Open to participants first (173), then studies with results posted, then the rest; newest registration first within each.
- Phase 2 Study Of Mosunetuzumab In Patients With Chronic Lymphocytic Leukemia With Positive MRDRecruitingNCT07566364Phase 2
- Halt Aging in Survivors of Blood CancersRecruitingNCT07292272Not applicable
- Use of a New Medicine "Daratumumab" to Treat Left-over Cancer in a Blood Cancer Called "T Acute Lymphoblastic Leukemia"RecruitingNCT07021677Phase 2
- National Longitudinal Cohort of Hematological Diseases-Large Granular Lymphocytic LeukemiaRecruitingNCT07019766
- Venetoclax + Azacytidine for Newly Diagnosed ETP-like ALL and T-ALL With Myeloid MutationsRecruitingNCT07012447Phase 2
- Phase II Trial of Zanubrutinib, Obinutuzumab, Bendamustine (ZGB) as First-Line Therapy for Chronic Lymphocytic Leukemia: A Single-Center StudyNot yet recruitingNCT07003464Phase 2
- Hepatoprotective for Children and Adolescent With Acute Lymphoblastic LeukemiaRecruitingNCT06918054Phase 4
- CD-19 CAR-T Cell for Pediatric ALL or LymphomaRecruitingNCT06866873Not applicable
- Time Restricted Eating in Haematological MalignanciesNot yet recruitingNCT06862323Phase 2
- Effectiveness and Safety of InO±DLI for Relapsed B-ALL/LBL After Allo-HSCTNot yet recruitingNCT06861348Phase 2
- Developing a Patient-Reported Outcome (PRO) Screening Measure for Infections and Measuring Quality of Life in Hematological Patients With Secondary Immunodeficiency (SID) Across the Treatment Trajectory - The PRO SID ProjectRecruitingNCT06821880
- Donor Derived CD19 CAR-T Cells in the Treatment of R/R B-cell Acute Lymphoblastic LeukemiaRecruitingNCT06793241Early Phase 1
- A Study of Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Treated With Lisocabtagene Maraleucel in the Post-Marketing SettingRecruitingNCT06788639
- Study of Nutrition and Exercise in Adults Hospitalized for Treatment of Acute Lymphoblastic Leukemia (ALL)RecruitingNCT06785324Not applicable
- Inaticabtagene Autoleucel (Inati-cel; CNCT19) Treatment for Newly Diagnosed B-cell ALL Patients in CR1Not yet recruitingNCT06777264Phase 2
- Venetoclax Combined With Olverembatinib and Predinisone in Treating Ph+ B-ALLRecruitingNCT06754267Phase 2
- CD19/CD22 CAR-T Cell Therapy in MRD-Positive B-lineage Acute Lymphoblastic Leukemia in Children.RecruitingNCT06752785Phase 1
- Role of Cbc Indices in Acute Lymphoblastic Leukemia PatientsNot yet recruitingNCT06746571Not applicable
- Virtual Reality During Lumbar Punctures in Acute Lymphoblastic LeukemiaRecruitingNCT06722638Not applicable
- Inaticabtagene Autoleucel (Inati-cel; CNCT19) Treatment for MRD-Positive B-ALL Patients in CR1RecruitingNCT06718244Phase 2
- Allogeneic CD19-targeted CAR-γδT Cell Infusion Therapy in Relapsed/Refractory B Cell Acute Lymphoblastic LeukemiaRecruitingNCT06696833Early Phase 1
- Systemic Inflammation Response Index and C-Reactive Protein to Albumin Ratio in Acute Lymphoblastic LeukemiaNot yet recruitingNCT06674850
- Olverembatinib as Maintenance Therapy or Preemptive Therapy After Allo-HSCT in Ph+ALLNot yet recruitingNCT06658925Phase 2
- Effects of a Strength Physical Exercise Program in Chronic Lymphocytic Leukemia PatientsNot yet recruitingNCT06654206Early Phase 1
- Reduced-Dose Chemo Followed by 14 Days of Blinatumomab for Newly Diagnosed Adult B-ALL Patients: a Multicenter StudyNot yet recruitingNCT06649422
- Clinical Research of CD19 Targeted CAR-T Cell in Relapsed/ Refractory B-ALLNot yet recruitingNCT06641024Phase 1
- Safety and Efficacy of CAR T Cell Therapy in Patients with R/r B-ALLRecruitingNCT06635330Phase 1/2
- Cell Therapy with Anti-CD19 CAR-NK Cells in Patients with Relapsed or Resistant B-ALLNot yet recruitingNCT06631040Phase 1/2
- Combination of Inaticabtagene Autoleucel With Autologous Hematopoietic Stem Cell Transplantation for Adolescents or Adults With MRD-Positive B-Cell Acute Lymphoblastic Leukemia in Initial Complete Remission.RecruitingNCT06608732Phase 2
- Autologous Hematopoietic Stem Cell Transplantation Combined With CD19-CART Treatment of Adult High-risk Acute Lymphoblastic LeukemiaRecruitingNCT06608342Phase 2
- Efficacy Study of Blinatumomab Clean Up Early Residual Disease for Newly Diagnosed Pediatric B Lymphoblastic LeukemiaRecruitingNCT06607419Phase 2/3
- BCL-2 Inhibitors Combined with the HyperCVAD Regimen for Newly Diagnosed T-lymphoblastic Leukemia/lymphoma.RecruitingNCT06598722Phase 2
- Bridging Allogeneic Hematopoietic Stem Cell Transplantation or Not After CD19 CAR - T (S1904) Cell Therapy for r/r B-cell Acute Lymphoblastic LeukemiaRecruitingNCT06581081Not applicable
- Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot TrialRecruitingNCT06580002Phase 2
- Chemotherapy-free Regimen of Venetoclax, Azacitidine Plus Orebatinib (VAO Regimen) for Newly Diagnosed ph+ALLRecruitingNCT06578546Phase 2
- A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of Haplo-HSCT Using a TBI or TMLI Conditioning Regimen for Adult ALLRecruitingNCT06564545Phase 2
- A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of MSD-HSCT Using a TBI or TMLI Conditioning Regimen for Pediatric ALLRecruitingNCT06564493Phase 2
- Effectiveness of Probiotics for the Prevention of Gastrointestinal Toxicity in Children with LeukemiaEnrolling by invitationNCT06560879Phase 2
- A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of Haplo-HSCT Using a TBI or TMLI Conditioning Regimen for Pediatric ALLRecruitingNCT06559345Phase 2
- The Real World Study of BTK Inhibitor in the Treatment of Chronic Lymphocytic Leukemia in ChinaNot yet recruitingNCT06557304
- A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of MSD-HSCT Using a TBI or TMLI Conditioning Regimen for Adult ALLRecruitingNCT06557161Phase 2
- Blinatumomab Plus Venetoclax Sequenced With Inotuzumab Ozogamicin in Treating B-ALLRecruitingNCT06554626Phase 2
- Efficacy of Risk-Stratified Treatment in Newly Diagnosed Infant LeukemiaRecruitingNCT06516679Phase 2
- The Real World Study of Zanubrutinib in the Treatment of Chronic Lymphocytic Leukemia in ChinaNot yet recruitingNCT06489184
- Description of the Immune Deficiency in Patients With Untreated Chronic Lymphocytic Leukemia and Search for Predictive Factors of Infectious RiskRecruitingNCT06475469Not applicable
- Prevention of GvHD in Participants With Hematological Malignancies Undergoing Hematopoietic Stem Cell Transplant (HSCT)RecruitingNCT06462365Phase 1
- Anti-CD19 Chimeric Antigen Receptor Modified T-cell (CAR-T) Therapy for Treatment of B-cell Hematological MalignanciesRecruitingNCT06462248Phase 2
- the Efficacy and Safety of Total Myeloid Irradiation (TMI) in the Treatment of Adult Acute Lymphoblastic LeukemiaNot yet recruitingNCT06461091
- Inaticabtagene Autoleucel Injection Treatment for Adult Relapsed or Refractory Acute Lymphocytic LeukemiaRecruitingNCT06450067
- CD19/CD22 CAR-T Cells in Adults With R/R ALL or NHLRecruitingNCT06445803Phase 1
- Blinatumomab Maintenance After Allo-HSCTNot yet recruitingNCT06438796Phase 2
- The Efficacy and Safety of Nelarabine Injection in Patients With T-lymphoblastic Leukemia and T-lymphoblastic LymphomaNot yet recruitingNCT06434467Phase 3
- Phase II Study of Post-Transplant Low-Dose Inotuzumab Ozogamicin to Prevent Relapse of Acute Lymphoblastic LeukemiaRecruitingNCT06427330Phase 2
- Sequential CAR-T Cells Therapy for CD5/CD7 Positive T-cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Using CD5/CD7-Specific CAR-T CellsRecruitingNCT06420076Phase 1/2
- Decitabine, Venetoclax and Blinatumomab for Maintenance Following HSCT in Patients With Ph-Negative B-ALLRecruitingNCT06393985Phase 2
- Observational Study on Invasive Fungal Infection Incidence in Ph-neg Acute Lymphoblastic Leukemia PatientsRecruitingNCT06392581
- Haplo-cord HCT vs. Haplo-HCT for T-ALL PatientsRecruitingNCT06381817Phase 3
- Investigating the Role of Energy Balance Modification on Health Responses in Chronic Lymphocytic LeukaemiaRecruitingNCT06379282Not applicable
- MRD Guided Sonrotoclax and Zanubrutinib in Newly Diagnosed CLL/SLLNot yet recruitingNCT06367374Phase 2
- Clinical Trial of ssCART-19 Cell Injection in the Treatment of Relapsed or Refractory Acute Lymphoblastic Leukemia (Including Central Nervous System Infiltration)Not yet recruitingNCT06367114Phase 2
- Biological and Clinical Efficacy of Shingrix in Patients With CLLNot yet recruitingNCT06364033Not applicable
- Blinatumomab for Relapsed Acute B Lymphoblastic Leukemia After TransplantationRecruitingNCT06339775Phase 4
- Ma-Spore ALL 2020 StudyRecruitingNCT06336395Phase 2
- Long Non-coding RNAs and Their Role on Epigenome as Diagnostic Markers in Childhood Acute Lymphoblastic Leukemia of T Cells.RecruitingNCT06334835
- The Safety and Efficacy of RD06-03 CART Cell Injection in Patients With R/R Acute B-lymphoblastic LeukemiaRecruitingNCT06307600Early Phase 1
- Raman Spectroscopy Compared to Flow CytometryRecruitingNCT06291428
- Treatment of CD19 Chimeric Antigen Receptor T Cells for Pediatric Patients With CD19-positive B-cell Acute Lymphoblastic Leukemia Who Are Indicated for Hematopoietic Stem Cell TransplantationRecruitingNCT06247501Phase 2
- Coagulopathy in Childhood Acute Lymphoblastic LeukaemiaNot yet recruitingNCT06242353
- MRD-associated Non-intensive But Non-interruptive Treatment of Ph-negative Acute Lymphoblastic Leukemia Adult PatientsRecruitingNCT06237192Not applicable
- A Single-arm, Open-label Study of Olverembatinib, CD3/CD19 Bispecific T-cell Engager, and Chidamide in Patients With Newly Diagnosed Ph+ALLRecruitingNCT06220487Phase 2
- INS19 CAR-T Cells for the Treatment of Relapsed or Refractory Acute B Lymphoblastic LeukemiaNot yet recruitingNCT06209671Phase 1
- CAR-T-19 Injection in the Treatment of CD19-positive Relapsed/Refractory B-ALLRecruitingNCT06179524Phase 2
- Treatment Protocol for Newky Diagnosed Adult Ph Positive ALLNot yet recruitingNCT06175702
- The Role of NK Cells to Detect Blood Infection in ALL.Not yet recruitingNCT06160115
- Short-term Blinatumomab as a Bridge Therapy for Allo-HSCT in Low Burden B-ALLRecruitingNCT06111625Phase 2
- A Prospective Clinical Study of Bridging alloHSCT After Treatment With Obinutuzumab in Combination With Chidamide and Venetoclax in RR Ph-ALL and B-cell Lymphoma PatientsNot yet recruitingNCT06087419Phase 1/2
- Outcomes of Unfit Patients With CLL Included in the GIMEMA LLC1114 Trial Who Discontinued Ibrutinib Due to Reasons Other Than Disease ProgressionNot yet recruitingNCT06084923
- Olverembatinib Plus Venetoclax and Dexamethasone for Treatment-naïve Ph+ Acute Lymphoblastic LeukemiaRecruitingNCT06082934Phase 1/2
- CD19/CD22 Bispecific CAR-T Cell Therapy for Relapsed/Refractory B-cell Lymphoma or Acute Lymphoblastic LeukemiaRecruitingNCT06081478Phase 2
- CD19CD22 CAR-T Therapy in Patients With High-Risk B Acute Lymphoblastic Leukemia (B-ALL).RecruitingNCT06078306Phase 2
- Blinatumomab Prevents Recurrence of R/R ALL After Allo-HSCTNot yet recruitingNCT06075238Phase 2
- Immune Reconstitution After Allo-HSCT and BlinatumomabNot yet recruitingNCT06075212
- Randomized Trial in Adult de Novo Ph Positive ALL With Chemotherapy, Imatinib or Ponatinib, Blinatumomab and SCTRecruitingNCT06061094Phase 2
- Thiotepa, Cyclophosphamide, Clarithromycin and CytarabineRecruitingNCT06060782Phase 1
- QH103 Cell Injection for the Treatment of Relapsed/Refractory B-cell Acute Lymphoblastic LeukemiaRecruitingNCT06056752Phase 1
- Bortezomib-based Regimen for Refractory or Relapsed Acute Lymphoblastic LeukemiaRecruitingNCT06034561Phase 2
- Retrospective Observational Study on Infective Complications and Outcome of Patients With ALL Treated With INORecruitingNCT06025682
- Adult Acute Lymphoblastic Leukemia Treated With Pediatric Regimen in BrazilRecruitingNCT05959720
- A Clinical Trial on the Safety and Efficacy of TQB3909 Tablets in Patients With Recurrent or Refractory Chronic Lymphocytic Leukemia (CLL) /Small Lymphocytic Lymphoma (SLL) .RecruitingNCT05959694Phase 1/2
- A Single Arm Study of Acalabrutinib Conbimed With Obinutuzumab in Chinese Patients With Previously Untreated CLLRecruitingNCT05950997Not applicable
- Effect of Supplementation With ω-3 Fatty Acids, Vitamin D and Calcium in Patients With Acute Lymphoblastic Leukemia.RecruitingNCT05950204Not applicable
- H19 in Acute Lymphoblastic Leukemia.Not yet recruitingNCT05943093
- Phase IV Observational Study of Orelabrutinib in the Treatment of Chronic Lymphocytic Leukemia/Small Cell LymphomaRecruitingNCT05920668
- Determining Clinical Study Experiences of Chronic Lymphocytic Leukemia PatientsNot yet recruitingNCT05899543
- Outcomes in Pediatric and Young Adult B-Cell Malignancies After Commercially Available ImmunotherapyRecruitingNCT05865301
- Mercaptopurine Therapeutic Drug Monitoring to Optimize the Maintenance Phase of Childhood ALLRecruitingNCT05811845
- Venetoclax+Azacytidine+Modified BUCY Conditioning Regimen for Acute Lymphoblastic Leukemia Undergoing Allo-HSCTRecruitingNCT05809167Phase 2
- Incidence of Severe COVID-19 Infection in Patients With CLL or B-NHL Who Received Pre-exposure Prophylaxis With Tixagevimab and Cilgavimab in Italy.RecruitingNCT05803395
- Clinical Study of Anti-CD1a CAR-T in the Treatment of R/R Acute T-lymphoblastic Leukemia/Lymphoblastic LymphomaRecruitingNCT05745181Phase 2
- Unravelling the Role of KCTD Protein Family in the Clinical Management of Childhood Acute Lymphoblastic LeukemiasRecruitingNCT05729178